Invesco Ltd. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$4,178,832
-17.4%
232,804
-6.6%
0.00%0.0%
Q2 2023$5,060,541
-2.0%
249,165
-12.0%
0.00%0.0%
Q1 2023$5,164,090
-8.3%
283,119
+4.0%
0.00%
-50.0%
Q4 2022$5,630,709
-19.2%
272,278
+2.2%
0.00%0.0%
Q3 2022$6,971,000
-19.3%
266,514
-21.8%
0.00%
-33.3%
Q2 2022$8,635,000
-6.8%
340,764
+16.1%
0.00%
+50.0%
Q1 2022$9,262,000
+15.2%
293,474
+47.7%
0.00%0.0%
Q4 2021$8,039,000
+2.6%
198,630
-11.6%
0.00%0.0%
Q3 2021$7,834,000
+30.6%
224,684
+2.9%
0.00%
+100.0%
Q2 2021$5,997,000
-28.3%
218,353
-26.7%
0.00%
-50.0%
Q1 2021$8,364,000
+5.7%
297,877
-2.3%
0.00%0.0%
Q4 2020$7,911,000
+61.3%
304,758
+6.5%
0.00%0.0%
Q3 2020$4,906,000
-32.0%
286,266
-1.8%
0.00%
-33.3%
Q2 2020$7,211,000
+81.5%
291,446
+1.8%
0.00%
+50.0%
Q1 2020$3,974,000286,2910.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders